The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Outsourced Drug Discovery Market Research Report 2024

Global Outsourced Drug Discovery Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1794914

No of Pages : 73

Synopsis
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
The global Outsourced Drug Discovery market was valued at US$ 17840 million in 2023 and is anticipated to reach US$ 34250 million by 2030, witnessing a CAGR of 11.1% during the forecast period 2024-2030.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
This report aims to provide a comprehensive presentation of the global market for Outsourced Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourced Drug Discovery.
Report Scope
The Outsourced Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Outsourced Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourced Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Segment by Application
Pharmaceutical Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourced Drug Discovery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Outsourced Drug Discovery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical Services
1.2.3 Biological Services
1.2.4 Lead Optimization
1.2.5 Lead Identification and Screening
1.3 Market by Application
1.3.1 Global Outsourced Drug Discovery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourced Drug Discovery Market Perspective (2019-2030)
2.2 Outsourced Drug Discovery Growth Trends by Region
2.2.1 Global Outsourced Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Outsourced Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Outsourced Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Outsourced Drug Discovery Market Dynamics
2.3.1 Outsourced Drug Discovery Industry Trends
2.3.2 Outsourced Drug Discovery Market Drivers
2.3.3 Outsourced Drug Discovery Market Challenges
2.3.4 Outsourced Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourced Drug Discovery Players by Revenue
3.1.1 Global Top Outsourced Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Outsourced Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Outsourced Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Outsourced Drug Discovery Revenue
3.4 Global Outsourced Drug Discovery Market Concentration Ratio
3.4.1 Global Outsourced Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourced Drug Discovery Revenue in 2023
3.5 Outsourced Drug Discovery Key Players Head office and Area Served
3.6 Key Players Outsourced Drug Discovery Product Solution and Service
3.7 Date of Enter into Outsourced Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourced Drug Discovery Breakdown Data by Type
4.1 Global Outsourced Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Outsourced Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Outsourced Drug Discovery Breakdown Data by Application
5.1 Global Outsourced Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Outsourced Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Outsourced Drug Discovery Market Size (2019-2030)
6.2 North America Outsourced Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Outsourced Drug Discovery Market Size by Country (2019-2024)
6.4 North America Outsourced Drug Discovery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourced Drug Discovery Market Size (2019-2030)
7.2 Europe Outsourced Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Outsourced Drug Discovery Market Size by Country (2019-2024)
7.4 Europe Outsourced Drug Discovery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourced Drug Discovery Market Size (2019-2030)
8.2 Asia-Pacific Outsourced Drug Discovery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Outsourced Drug Discovery Market Size by Region (2019-2024)
8.4 Asia-Pacific Outsourced Drug Discovery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourced Drug Discovery Market Size (2019-2030)
9.2 Latin America Outsourced Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Outsourced Drug Discovery Market Size by Country (2019-2024)
9.4 Latin America Outsourced Drug Discovery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourced Drug Discovery Market Size (2019-2030)
10.2 Middle East & Africa Outsourced Drug Discovery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Outsourced Drug Discovery Market Size by Country (2019-2024)
10.4 Middle East & Africa Outsourced Drug Discovery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Detail
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Outsourced Drug Discovery Introduction
11.1.4 IQVIA Revenue in Outsourced Drug Discovery Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Detail
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Outsourced Drug Discovery Introduction
11.2.4 Charles River Laboratories Revenue in Outsourced Drug Discovery Business (2019-2024)
11.2.5 Charles River Laboratories Recent Development
11.3 Aptuit
11.3.1 Aptuit Company Detail
11.3.2 Aptuit Business Overview
11.3.3 Aptuit Outsourced Drug Discovery Introduction
11.3.4 Aptuit Revenue in Outsourced Drug Discovery Business (2019-2024)
11.3.5 Aptuit Recent Development
11.4 Evotec
11.4.1 Evotec Company Detail
11.4.2 Evotec Business Overview
11.4.3 Evotec Outsourced Drug Discovery Introduction
11.4.4 Evotec Revenue in Outsourced Drug Discovery Business (2019-2024)
11.4.5 Evotec Recent Development
11.5 GenScript
11.5.1 GenScript Company Detail
11.5.2 GenScript Business Overview
11.5.3 GenScript Outsourced Drug Discovery Introduction
11.5.4 GenScript Revenue in Outsourced Drug Discovery Business (2019-2024)
11.5.5 GenScript Recent Development
11.6 PPD
11.6.1 PPD Company Detail
11.6.2 PPD Business Overview
11.6.3 PPD Outsourced Drug Discovery Introduction
11.6.4 PPD Revenue in Outsourced Drug Discovery Business (2019-2024)
11.6.5 PPD Recent Development
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Detail
11.7.2 WuXi AppTec Business Overview
11.7.3 WuXi AppTec Outsourced Drug Discovery Introduction
11.7.4 WuXi AppTec Revenue in Outsourced Drug Discovery Business (2019-2024)
11.7.5 WuXi AppTec Recent Development
11.8 AMRI
11.8.1 AMRI Company Detail
11.8.2 AMRI Business Overview
11.8.3 AMRI Outsourced Drug Discovery Introduction
11.8.4 AMRI Revenue in Outsourced Drug Discovery Business (2019-2024)
11.8.5 AMRI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’